Suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
rate	rate	O	O	O	O
and	and	O	O	O	O
observed	observed	O	O	O	O
fasciculations	fasciculations	O	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
dose-response	dose-response	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

Suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
chloride	chloride	O	O	OTHERS	I
(	(	O	O	O	O
Sch	sch	O	O	OTHERS	I
)	)	O	O	O	O
was	was	O	O	O	O
administered	administered	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O
to	to	O	O	O	O
36	36	O	O	O	O
adult	adult	O	O	O	O
males	males	O	O	O	O
at	at	O	O	O	O
six	six	O	O	O	O
rates	rates	O	O	O	O
:	:	O	O	O	O
0.25	0.25	O	O	O	O
mg	mg	O	O	OTHERS	I
s-1	s-1	O	O	O	O
to	to	O	O	O	O
20	20	O	O	O	O
mg	mg	O	O	OTHERS	I
s-1	s-1	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
infusion	infusion	O	O	O	O
was	was	O	O	O	O
discontinued	discontinued	O	O	O	O
either	either	O	O	O	O
when	when	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
no	no	O	O	O	O
muscular	muscular	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
tetanic	tetanic	O	O	OTHERS	I
stimulation	stimulation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
ulnar	ulnar	O	O	O	O
nerve	nerve	O	O	O	O
or	or	O	O	O	O
when	when	O	O	O	O
Sch	sch	O	O	OTHERS	I
120	120	O	O	O	O
mg	mg	O	O	OTHERS	I
was	was	O	O	O	O
exceeded	exceeded	O	O	O	O
.	.	O	O	O	O

Six	six	O	O	O	O
additional	additional	O	O	O	O
patients	patients	O	O	O	O
received	received	O	O	O	O
a	a	O	O	O	O
30-mg	30-mg	O	O	O	O
i.v	i.v	O	O	O	O
.	.	O	O	O	O

bolus	bolus	O	O	O	O
dose	dose	O	O	O	O
.	.	O	O	O	O

Fasciculations	fasciculations	O	O	OTHERS	I
in	in	O	O	O	O
six	six	O	O	O	O
areas	areas	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
body	body	O	O	O	O
were	were	O	O	O	O
scored	scored	O	O	O	O
from	from	O	O	O	O
0	0	O	O	O	O
to	to	O	O	O	O
3	3	O	O	O	O
and	and	O	O	O	O
summated	summated	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
total	total	O	O	O	O
fasciculation	fasciculation	O	DISEASE	OTHERS	I
score	score	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
times	times	O	O	O	O
to	to	O	O	O	O
first	first	O	O	O	O
fasciculation	fasciculation	O	DISEASE	OTHERS	I
,	,	O	O	O	O
twitch	twitch	O	O	OTHERS	I
suppression	suppression	O	O	O	O
and	and	O	O	O	O
tetanus	tetanus	O	O	OTHERS	I
suppression	suppression	O	O	O	O
were	were	O	O	O	O
inversely	inversely	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
infusion	infusion	O	O	O	O
rates	rates	O	O	O	O
.	.	O	O	O	O

Fasciculations	fasciculations	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
six	six	O	O	O	O
areas	areas	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
total	total	O	O	O	O
fasciculation	fasciculation	O	DISEASE	OTHERS	I
score	score	O	O	O	O
were	were	O	O	O	O
related	related	O	O	O	O
directly	directly	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
infusion	infusion	O	O	O	O
.	.	O	O	O	O

Total	total	O	O	O	O
fasciculation	fasciculation	O	DISEASE	OTHERS	I
scores	scores	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
30-mg	30-mg	O	O	O	O
bolus	bolus	O	O	O	O
group	group	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
5-mg	5-mg	O	O	O	O
s-1	s-1	O	O	O	O
and	and	O	O	O	O
20-mg	20-mg	O	O	O	O
s-1	s-1	O	O	O	O
infusion	infusion	O	O	O	O
groups	groups	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
significantly	significantly	O	O	O	O
different	different	O	O	O	O
.	.	O	O	O	O

